Cambridge Investment Research Advisors’s U.S. Core Equity 1 Portfolio ETF Class Shares DCOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.5M Buy
298,555
+36,842
+14% +$2.92M 0.05% 356
2026
Q1
$18.9M Buy
261,713
+14,713
+6% +$1.1M 0.05% 392
2025
Q4
$18.2M Buy
247,000
+9,375
+4% +$682K 0.05% 393
2025
Q3
$17.1M Buy
237,625
+8,648
+4% +$601K 0.05% 404
2025
Q2
$15.3M Buy
228,977
+35,717
+18% +$2.22M 0.05% 407
2025
Q1
$11.9M Buy
193,260
+132,412
+218% +$8.53M 0.04% 442
2024
Q4
$3.9M Buy
60,848
+9,492
+18% +$618K 0.01% 940
2024
Q3
$3.25M Buy
51,356
+10,836
+27% +$660K 0.01% 1033
2024
Q2
$2.41M Buy
40,520
+17,870
+79% +$1.04M 0.01% 1162
2024
Q1
$1.33M Buy
+22,650
New +$1.26M 0.01% 1535

Other funds holding DCOR

Cambridge Investment Research Advisors's DCOR Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its U.S. Core Equity 1 Portfolio ETF Class Shares (DCOR) stake by 14% in Q2 2026, buying an estimated $2.92M and bringing the position to 298,555 shares worth $24.5M. The position accounts for 0.05% of the portfolio, ranked #356.

Cambridge Investment Research Advisors first reported a position in DCOR in Q1 2024 and has held it in 10 quarters since. 242 funds tracked by Wall St. Rank hold DCOR as of Q2 2026.

  • Cambridge Investment Research Advisors held 298,555 shares of U.S. Core Equity 1 Portfolio ETF Class Shares worth $24.5M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 36,842 U.S. Core Equity 1 Portfolio ETF Class Shares shares in Q2 2026, an estimated $2.92M.
  • U.S. Core Equity 1 Portfolio ETF Class Shares made up 0.05% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #356 holding.
  • Cambridge Investment Research Advisors first reported a position in U.S. Core Equity 1 Portfolio ETF Class Shares in Q1 2024 and has held it in 10 quarters since.
  • 242 funds tracked by Wall St. Rank held U.S. Core Equity 1 Portfolio ETF Class Shares as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.